UFP Technologies, Inc. (UFPT) Stock Forecast and Price Target (2026)
Last updated July 2026
Short answer
There is no meaningful analyst consensus for UFP Technologies, Inc. (UFPT): too few analysts publish estimates on it for an average target to mean anything. That is normal for smaller and newer companies and says nothing about the business. What is left is the setup, the drivers and the risks below, which you assess yourself rather than starting from someone else's model. Walnut is not an investment adviser.
Why UFPT has no consensus price target
Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with UFPT. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.
At about ~$304 per share on ~7.75 million shares outstanding, UFPT carries a market value near ~$2.36 billion, which is roughly ~33 times trailing earnings and roughly ~3.7 times trailing revenue. That is a premium to most contract manufacturers, reflecting the medical mix, the ~29% gross margin and a multi-year record of double-digit growth. The balance sheet is light, with ~$117 million of long-term debt against a ~$275 million facility maturing in June 2029.
What could move UFPT from here
In short: the drivers cited most often are The Intuitive Surgical contract, now written through 2029, Shifting production to the Dominican Republic and Mexico, Growth is broadening past the biggest accounts. The risk cited most often against it is customer concentration is the first-order risk: two customers accounted for approximately ~24.3% and ~21.5% of 2025 net sales, and the company's own risk factors flag the possibility that Intuitive Surgical could decide to manufacture the products itself or through another supplier.
Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the UFPT is it a buy page. This page deliberately stops at the numbers.
Investing in UFP Technologies, Inc. with AI
Connect the broker you already use and ask Walnut's AI how UFPT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the price target for UFP Technologies, Inc. (UFPT)?
+
There is no meaningful consensus price target for UFPT, because too few analysts publish on it. That is common for smaller and newer companies. Where only one or two analysts cover a stock, an "average target" is really one person's model, so we do not print a number that would imply more agreement than exists. Check your broker's research tab for whatever individual coverage exists.
Why does UFPT have no analyst forecast?
+
Sell-side coverage follows trading volume and banking relationships, so small caps, recent listings, and companies outside the major indices often carry little or none. A lack of coverage says nothing about the business itself. It does mean you are doing the analysis yourself rather than starting from someone else's model.
What could move UFPT?
+
The drivers and the risks are laid out on this page and in more depth on the UFPT "is it a buy" page. Without analyst estimates to anchor to, the honest framing is scenarios rather than a number.
Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a August 2026 data pull of published third-party research, are approximate, and change constantly. Verify current figures with your broker before acting on them.